Welcome to Iris Biotech
For better service please confirm your country and language we detected.
Währung
EUR
Blog | Page 31
-
Product of the Month: cyclo-Arg-Gly-Asp (RGD) Peptides
The integrin receptor interacting RGD sequence and related peptides act as promising tools for drug therapy and cancer research. Find more information on our portfolio of cyclic RGD peptides.
Weiterlesen
-
L-Cysteine from non-human/non-animal origin
Iris Biotech offers L-Cysteine Hydrochloride Monohydrate from Cystine, which is produced by fermentation of Escherichia coli.
Weiterlesen
-
Product of the Month: “Cleland’s Reagent” Dithiothreitol (DTT)
DTT is a powerful yet mild reducing agent. Based on your demand we can offer different quality grades to suit your needs.
Weiterlesen
-
Phenyl-, Cyclohexyl- and BCP-Amino Acids
Sidechain-derivatized amino acids have shown great potential in enhancing select properties of peptide lead compounds. Find the most recent additions to our portfolio of amino acids bearing additional aryl and alkyl groups in their side chains.
Weiterlesen
-
PotM: Peptide Easy Clean (PEC)
Peptide purification after SPPS usually requires time- and solvent-consuming HPLC, which is often limited by co-eluting side-products. Belyntic’s catch-and-release PEC-Linker chemoselectively catches the desired product from your crude to reach a new dimension of purity.
Weiterlesen
-
Lipidated Amino Acids
The tremendous success of Liraglutide and Semaglutide has moved amino acids modified with lipids into the focus of many research endeavors. Delve into the treasure trove of our lipidated amino acids!
Weiterlesen
-
PotM: Bicyclo[1.1.1]pentanes as Phenyl Ring Bioisosteres
The presence of phenyl groups in APIs is connected with various disadvantages. An increasingly popular solution is the use of BCP as a phenyl ring bioisostere. Find out more about this highly diversifiable motif.
Weiterlesen![PotM: Bicyclo[1.1.1]pentanes as Phenyl Ring Bioisosteres](https://cdn.iris-biotech.de/media//_cache/images/blog/610/potm_bcp_teaser.jpg)
-
Statement on COVID-19
Beginning of March 2020 Iris Biotech implemented measures in order to minimize the impact of and the risks associated with the current pandemic. As of 26 March 2020, Iris Biotech is classified as system-relevant.
Weiterlesen
-
-
